The CDISC European Interchange in Copenhagen saw a surge of interest this year and with that a significant increase in numbers. Over 300 attendees enjoyed events across the week (21st – 25th April 2008). This increase reflects the growth in adoption of CDISC (Clinical Data Interchange Standards Consortium) standards in Europe and the more mature audience contributed enormously to the lively sessions. Tim Jaeger, Chairman of the European CDISC Coordinating Committee, said: “This year our dramatic increase in numbers demonstrates how important CDISC is to medical research in the European Union and beyond; we are proud to have welcomed both our well established and new delegates to Copenhagen.” Read the press release. Also indicative of growing interest in clinical data standards, the organization lists vendors whose products have received CDISC Operational Data Model (ODM) certification. 

OmniComm Systems announced that City of Hope, a National Cancer Institute (NCI)-designated comprehensive cancer center, has gone live using TrialMaster for EDC in the first of many trials that will benefit from using a unique library of NCI-related reusable electronic case report forms developed by OmniComm and City of Hope. The trial, coordinated by City of Hope on behalf of the California Cancer Consortium, will enroll between 72 and 132 patients and will involve at least 17 participating centers, including international sites. Read the press release. 

Accelerated Community Oncology Research Network (ACORN), an oncology-focused CRO and research network, announced today its expansion of the company's aggregated information portfolio with a proprietary oncology-focused data warehouse. Integrating patient-reported outcomes (PROs), electronic medical records (EMR), claims data, and laboratory information systems, garnered from community oncology practices nationwide where 85 percent of cancer care is provided, ACORN's data warehouse offers reliable information solutions to payers, financial institutions, pharmaceutical / biotech companies, and community oncology practices.

Medidata Solutions and Clinsys Clinical have partnered through Medidata’s ASPire to Win program. The partnership will enable Clinsys to implement the Medidata Rave technology for capturing, managing and reporting clinical data as a complement to its focus on superior service delivery for sponsors in the U.S., Europe and India. Read the press release.

Veeda Oncology, a specialist CRO, has selected TrialWorks by ClinPhone to further strengthen its clinical trial management capabilities. Veeda Oncology will implement TrialWorks across its four major sites in India, France, Germany and the USA, providing international team members with real-time, immediate access to the company's clinical trial management data and reports. Read the press release.

Good Products, a provider of Enterprise Content Management (ECM) solutions for the pharmaceutical, biotechnology and medical device sectors has launched its new Clinical Technology Consulting division. Designed to enable biopharmaceutical sponsors and CROs to optimize their use of clinical technology, Good Products' new consulting division offers remote and on-site expertise throughout North America and Europe. Website: